CN1116938A - Extraction of Rhizoma Drynariae active principle - Google Patents

Extraction of Rhizoma Drynariae active principle Download PDF

Info

Publication number
CN1116938A
CN1116938A CN 94111121 CN94111121A CN1116938A CN 1116938 A CN1116938 A CN 1116938A CN 94111121 CN94111121 CN 94111121 CN 94111121 A CN94111121 A CN 94111121A CN 1116938 A CN1116938 A CN 1116938A
Authority
CN
China
Prior art keywords
rhizoma drynariae
extraction
active ingredient
organic solvent
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 94111121
Other languages
Chinese (zh)
Inventor
龙勉
鲁树坤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 94111121 priority Critical patent/CN1116938A/en
Publication of CN1116938A publication Critical patent/CN1116938A/en
Pending legal-status Critical Current

Links

Abstract

The Chinese medicinal material Rhizoma Drynariae is processed through water decoction, organic solvent extraction or reflux to obtain its active component. It is used in preventing and curing the toxic by-effect of amino-carbohydrate antibiotic, promoting hair growth, promoting bone regeneration and reinforcing kidney. It is prepared into injecta, liniment, pill or tablet, and without any toxic by-effect.

Description

The extraction of Rhizoma Drynariae active ingredient
The present invention relates to the extraction of Chinese medicine Rhizoma Drynariae active ingredient.
Rhizoma Drynariae is a kind of Chinese medicine, presses the theoretical kidney-reinforcing drug that belongs to of Chinese medicine, up to the present, its active ingredient is not extracted as yet be applied to clinical.
The purpose of this invention is to provide and a kind ofly can be applied to clinical, better efficacy, use the extracting method of Rhizoma Drynariae active ingredient more easily and its clinical practice.
The object of the present invention is achieved like this:
The extracting method of Rhizoma Drynariae active ingredient may further comprise the steps:
1) add 5-20 times of water in Rhizoma Drynariae, heating decocts 1-3 time;
2) filter, filtrate is concentrated into flowing soaking paste;
3) use fluid extract: the alcohols of organic solvent=1: 5~15 volume ratios, lipid, ketone, the active ingredient of alkanes organic solvent extraction.
The present invention can also realize by following steps:
Use Rhizoma Drynariae: organic solvent=1: the alcohols of 5-15 weight ratio, lipid, ketone, the distillation of alkanes organic solvent reflux were extracted in 0.5-1 hour.
The active ingredient that above step is extracted has following feature:
On the silica gel column chromatography plate with positive six alkane: acetone: having Rf value after ethanol=7.5: 7: 0.1 launches is 0.5-0.3; And has a ultra-violet absorption speckle more than 4.
This active ingredient has following pharmacological action after deliberation:
1). the effect of paying of control Aminoglycoside antibiotics;
Prove that in the guinea pig zoopery use gentamycin to use the animal of Rhizoma Drynariae working substance injection again simultaneously, the damage of its cochlear hair cell and hearing impairment obviously are lighter than and accept the gentamycin group merely.To the epithelial damage of the nearly curved tube of kidney, the Rhizoma Drynariae working substance shows the repair after significant protective effect and the damage.
The application of Rhizoma Drynariae extract does not change gentamycin haemoconcentration in animal body.Do not influence the antibacterial effect of gentamycin yet.
2). promote hair regeneration;
3). promote inostosis;
4). treatment nephropathy and enhancing renal function.
Above extract can be made into injection type, tablet form, pill-type medicine, also can be made into the liquid dosage form medicine for external application.
This extract is easy to use, and good effect is nontoxic, have no side effect.
Embodiment 1:
1). Rhizoma Drynariae 50g, add water 500ml and boil and fry in shallow oil 0.5 hour;
2). filter, steam to flowing soaking paste;
3). with 95% ethanol 20ml, extracted 10 minutes;
4). make injection type.
Be applied to prevent and treat the toxic and side effects of antibiotics.
Embodiment 2:
Rhizoma Drynariae 20g, with 95% ethanol 200ml, cohobation 0.5 hour.
Filter, get the Rhizoma Drynariae active ingredient, make liquid and be coated with dosage form outward, be applied to prevent and treat alopecia, promote hair regeneration.

Claims (3)

1. the extraction of Rhizoma Drynariae active ingredient is characterized in that may further comprise the steps:
1). add 5-20 times of water in Rhizoma Drynariae, heating decocts 1-3 time;
2). filter, filtrate is concentrated into flowing soaking paste;
3). use fluid extract: the alcohols of organic solvent=1: 5~15 volume ratios, lipid, ketone, the active ingredient of alkanes organic solvent extraction.
2. the extraction of Rhizoma Drynariae active ingredient is characterized in that with 1: 5-15 times of alcohols, and lipid, ketone, the distillation of alkanes organic solvent reflux was extracted in 0.5-1 hour.
3. according to the extraction of claim 1 or 2 described Rhizoma Drynariae active ingredients, it is characterized in that active ingredient has following feature: on the silica gel column chromatography plate with positive six alkane: acetone: having Rf value after ethanol equals to launch at 7.5: 7: 0.1 is 0.5-0.3; And uv absorption mottle more than four arranged.
CN 94111121 1994-08-18 1994-08-18 Extraction of Rhizoma Drynariae active principle Pending CN1116938A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 94111121 CN1116938A (en) 1994-08-18 1994-08-18 Extraction of Rhizoma Drynariae active principle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 94111121 CN1116938A (en) 1994-08-18 1994-08-18 Extraction of Rhizoma Drynariae active principle

Publications (1)

Publication Number Publication Date
CN1116938A true CN1116938A (en) 1996-02-21

Family

ID=5035021

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 94111121 Pending CN1116938A (en) 1994-08-18 1994-08-18 Extraction of Rhizoma Drynariae active principle

Country Status (1)

Country Link
CN (1) CN1116938A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053164A1 (en) * 2000-12-29 2002-07-11 Qihuang Pharmaceutical Technology And Investment Co., Ltd. Drynaria extractions for treating osteoporosis and their extraction process

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053164A1 (en) * 2000-12-29 2002-07-11 Qihuang Pharmaceutical Technology And Investment Co., Ltd. Drynaria extractions for treating osteoporosis and their extraction process
US7122214B2 (en) 2000-12-29 2006-10-17 Qihuang Pharmaceutical Technology And Investment Co., Ltd. Drynaria extractions for treating osteoporosis and their extraction process
CN100418521C (en) * 2000-12-29 2008-09-17 北京岐黄制药有限公司 Gusuibu extracts for trvating osteoporosis and method for extracting same

Similar Documents

Publication Publication Date Title
CN100534511C (en) Combined Chinese-Western medicine mixture for treating mycotic skin disease, and its use method
CN1116938A (en) Extraction of Rhizoma Drynariae active principle
CN101485701B (en) Method for preparing total polyphenol of Loropetalum chinense (R. Br.) Oliver for treating burn and scald
CN102626477B (en) Externally used traditional Chinese medicine combination for treating long-time traumatic injury
CN1060943C (en) Composite pharmaceutics made of oldenlandia and usage thereof
CN1172691C (en) Cholelithiasis treating medicine
DE60003453T2 (en) PHYTOTHERAPEUTIC PREPARATION
CN1180540A (en) Compound beri-beri liquid
CN102038813A (en) Coconut palm leaf extract and preparation method and use thereof
CN111375030A (en) Traditional Chinese medicine gel for treating skin itch
CN1108136A (en) Multi-function medicinal liquor for invigorating primordial qi and the prepn. method
CN1170559C (en) Capsule for removing heat from liver and detoxicating and its preparing process
CN1259948C (en) External-applying treating liquid for rhinitis and common cold, and its preparation method thereof
Parasuraman et al. Wound healing agents from natural sources
Mohiuddin et al. A comprehensive biological, ethno-pharmacological and phytochemical update review on ayurvedic plant of Terminalia chebula (HORTOKI) of Bangladesh
CN1060652C (en) Rhinitis liniment and its prepn.
CN1061258C (en) Shennong powder for Hong Kong foot and preparation thereof
CN1188658A (en) 'Lanweiling' oral liquid for treating appendicitis
CN110251564B (en) External medicine for treating gouty arthritis and preparation method thereof
CN1069210C (en) Liquid for curing scald and burn and its preparing method
CN106359465A (en) Botanical composition for treating grape powdery mildew and preparation method thereof
DE19633446A1 (en) A composition comprises several lipid lowering plant extracts
CN1301119C (en) External use traditional Chinese medicine for treating beriberi
CN109602678A (en) A kind of cosmetics Chinese medicine composition and preparation method thereof
CN1555875A (en) Notoginseng ginkgo health care food and its preparation method

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication